XML 116 R38.htm IDEA: XBRL DOCUMENT v3.25.0.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2024
Income Tax Disclosure [Abstract]  
Schedule of Income Tax Expense
The components of the income tax expense for the years ended December 31, 2024 and 2023 (in thousands) were:
Year Ended December 31,
20242023
Current:
  Federal
$891 $14,962 
  State
(32)3,779 
  Foreign
— — 
     Total current tax provision
859 18,741 
Deferred:
  Federal— — 
  State— — 
  Foreign— — 
     Total deferred tax provision
— — 
Total income tax provision
$859 $18,741 
Schedule of Reconciliation of U.S. Federal Statutory Income Tax Rate to Effective Income Tax Rate
A reconciliation of the U.S. federal statutory income tax rate to the Company’s effective income tax rate is as follows:
Year Ended December 31,
20242023
Federal statutory income tax rate21.0%21.0%
State income taxes, net of federal benefit3%5%
Other Permanent differences3%— %
Federal and state research and development tax credits(8)%(50)%
Non-deductible stock compensation and non-taxable items%11 %
Change in deferred tax asset valuation allowance(23)%170 %
 Federal and State 453A interest2%— %
Change in state tax rates—%(2)%
Effective income tax rate1.3%155.5%
Schedule of Net Deferred Tax Assets
Net deferred tax assets as of December 31, 2024 and 2023 consisted of the following (in thousands):
December 31,
20242023
Deferred tax assets:
Net operating loss carryforwards$1,264$3,617
Research and development tax credit carryforwards4,5282,706
Intangible assets3,0352,326
Capitalized research and development expenses51,43332,803
Deferred revenue5,39936,726
Lease liability16,48722,581
Stock compensation2,4201,709
Other Assets94
Total deferred tax assets84,660102,468
Deferred tax liabilities:
Property and equipment(1,093)(2,044)
Right-of-use asset(19,439)(22,237)
Prepaid expenses(336)(281)
Other liabilities(854)— 
Total deferred liabilities(21,722)(24,562)
Valuation allowance(62,938)(77,906)
Net deferred tax assets$$